--(BUSINESS WIRE)--TRACON Pharmaceuticals, Inc. is a fast growing private biotechnology company developing targeted therapies for cancer and related diseases. We seek to address unmet needs with product candidates that focus on cellular targets specifically implicated in cancer growth and angiogenesis. Our drug candidates have been selected, in part, for their advantageous side effect profiles and will be developed to combine easily with existing therapies.
